Biochemical Characterization of the Two-Component Flavin-Dependent Monooxygenase Involved in Valanimycin Biosynthesis

Hao Li,Benedicta Forson,Meital Eckshtain-Levi,Hannah Valentino,John J. Tanner,Pablo Sobrado,Julia S. Martín del Campo
DOI: https://doi.org/10.1021/acs.biochem.0c00679
IF: 3.321
2020-12-22
Biochemistry
Abstract:The flavin reductase (FRED) and isobutylamine <i>N</i>-hydroxylase (IBAH) from <i>Streptomyces viridifaciens</i> constitute a two-component, flavin-dependent monooxygenase system that catalyzes the first step in valanimycin biosynthesis. FRED is an oxidoreductase that provides the reduced flavin to IBAH, which then catalyzes the hydroxylation of isobutylamine (IBA) to isobutylhydroxylamine (IBHA). In this work, we used several complementary methods to investigate FAD binding, steady-state and rapid reaction kinetics, and enzyme–enzyme interactions in the FRED:IBAH system. The affinity of FRED for FAD<sub>ox</sub> is higher than its affinity for FAD<sub>red</sub>, consistent with its function as a flavin reductase. Conversely, IBAH binds FAD<sub>red</sub> more tightly than FAD<sub>ox</sub>, consistent with its role as a monooxygenase. FRED exhibits a strong preference (28-fold) for NADPH over NADH as the electron source for FAD reduction. Isothermal titration calorimetry was used to study the association of FRED and IBAH. In the presence of FAD, either oxidized or reduced, FRED and IBAH associate with a dissociation constant of 7–8 μM. No interaction was observed in the absence of FAD. These results are consistent with the formation of a protein–protein complex for direct transfer of reduced flavin from the reductase to the monooxygenase in this two-component system.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.biochem.0c00679?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.biochem.0c00679</a>.Figures and table with data from the purification of enzymes (IBAH and FRED), NADPH-oxidase activity of FRED, MS analysis of the IBAH product formation assay, and ITC characterization of ligand–enzyme binding (<a class="ext-link" href="/doi/suppl/10.1021/acs.biochem.0c00679/suppl_file/bi0c00679_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
biochemistry & molecular biology
What problem does this paper attempt to address?